Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer Article (Web of Science)

cited authors

  • Han, Zhengyang; Rimal, Ujjwal; Khatiwada, Prabesh; Brandman, Jacob; Zhou, Jun; Hussain, Muhammad; Viola, Ronald E.; Shemshedini, Lirim

publication date

  • November 14, 2022

webpage

published in

category

keywords

  • Polycomb repressive complex 2
  • androgen receptor
  • castration-resistant prostate cancer
  • peptides

volume

  • 164

issue

  • 1